Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Ann Epidemiol. 2014 Feb 8;24(5):369–375. doi: 10.1016/j.annepidem.2014.01.012

Table 2.

Unadjusted hazard rate ratios for baseline patient characteristics associated with death during TB treatment among patients in the state of Georgia, 2009–2012

Patient characteristic
(at TB treatment start)
Died
N=83/1238 (6.7)
Died/N (%)
cHR (95% CI)

Diabetes mellitus
  No 66/1089 (6.1) 1.00
  Yes 17/149 (11.4) 1.88 (1.10, 3.20)

Age (years)
  16–34 6/402 (1.5) 1.00
  35–44 9/213 (4.2) 2.78 (0.99, 7.8)
  45–54 19/276 (6.9) 4.58 (1.83,11.48)
  ≥55 49/347 (14.1) 10.24 (4.39, 23.92)

Sex
  Female 14/414 (3.4) 1.00
  Male 69/824 (8.4) 2.55 (1.44, 4.53)

Race/ethnicity
  White 20/194 (10.3) 1.00
  NH Black 54/592 (9.1) 0.85 (0.51, 1.42)
  NH Asian 4/220 (1.8) 0.17 (0.06, 0.49)
  Hispanic 5/226 (2.2) 0.21 (0.08, 0.56)

Occupation
  Employed 11/492 (2.2) 1.00
  Unemployed 34/479 (7.1) 3.17 (1.61, 6.26)
  Retired 24/124 (19.4) 9.87 (4.83, 20.16)
  Other/unknown 14/143 (9.8) 4.84 (2.20,10.66)

Foreign born
  No 69/669 (10.3) 1.00
  Yes 14/568 (2.5) 0.24 (0.13, 0.42)

Recent homeless
  No 75/1111 (6.8) 1.00
  Yes 7/124 (5.7) 0.80 (0.37, 1.74)

Currently in correctional facility
  No 81/1132 (7.2) 1.00
  Yes 1/103 (1.0) 0.14 (0.02, 1.03)

Heavy alcohol use
  No/unknown 65/1047 (6.2) 1.00
  Yes 18/191 (9.4) 1.51 (0.90, 2.55)

Drug use
  No 73/1113 (6.6) 1.00
  Yes 6/117 (5.1) 0.73 (0.32, 1.68)

End stage renal disease
  No 75/1206 (6.2) 1.00
  Yes 8/32 (25.0) 4.21 (2.03, 8.73)

HIV serologic status
  Negative/unknown 68/1098 (6.2) 1.00
  Positive 15/140 (10.7) 1.59 (0.90, 2.79)

AFB sputum smear status
  Negative 33/655 (5.0) 1.00
  Positive 35/498 (7.0) 1.40 (0.87, 2.25)
  Unknown 15/85 (17.7) 3.74 (2.03, 6.89)

Baseline culture
  Negative/unknown 12/298 (4.0) 1.00
  Positive 71/940 (7.6) 1.86 (1.01, 3.43)

TB site of disease
  Pulmonary only 56/913 (6.1) 1.00
  Pulmonary and extra-pulmonary 11/105 (10.5) 1.67 (0.87, 3.18)
  Extra-pulmonary only 16/220 (7.3) 1.09 (0.63, 1.91)

Previous TB treatment
  No 78/1167 (6.7) 1.00
  Yes 4/70 (5.7) 0.86 (0.31, 2.34)

Cavitary lung disease on chest radiograph at time of TB diagnosis
  No 54/780 (6.9) 1.00
  Yes 28/427 (6.6) 0.95 (0.60, 1.51)

Miliary/Disseminated TB
  No 78/1187 (6.6) 1.00
  Yes 5/51 (9.8) 1.51 (0.61, 3.72)

Drug Susceptibility
  None to RIF or INH 59/827 (7.1) 1.00
  Single Drug (RIF or INH) 7/96 (7.3) 0.97 (0.44, 2.13)
  MDR-TB 1/6 (16.7) 1.86 (0.26, 13.57)
  Unavailable 16/309 (5.2) 0.73 (0.42, 1.27)

Abbreviations: cHR-crude hazard ratio; CI-confidence interval; STD-standard deviation; IQR-interquartile range; NH-Non-Hispanic; RIF-Rifampin; INH-Isoniazid; AFB-acid fast bacilli; MDR-multi-drug resistant (resistance to at least both INH and RIF)